AAAAAA

   
Results: 1-25 | 26-50 | 51-64
Results: 26-50/64
PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR SYSTEMIC AMYLOIDOSIS (AL) - A REPORT ON 22 CASES
Authors: MOREAU P LEBLOND V BOURQUELOT P FACON T ATTAL M CAILLOT D AUDHUY B NEDELLEC G HUYNH A FERRANT A BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR SYSTEMIC AMYLOIDOSIS (AL) - A REPORT ON 22 CASES, Blood, 90(10), 1997, pp. 490-490
ATRA FOLLOWED BY CHEMOTHERAPY (CT) VS ATRA PLUS CT AND THE ROLE OF MAINTENANCE THERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIRST INTERIM RESULTS OF APL-93 TRIAL
Authors: FENAUX P CHASTANG C SANZ M THOMAS X DOMBRET H LINK H GUERCI A FEGUEUX N SANMIGUEL J RAYON C ZITTOUN R GARDIN C MALOISEL F FEY M TRAVADE P REIFFERS J STAMATOULAS A STOPPA AM CAILLOT D LEFRERE F HAYAT M CASTAIGNE S CHOMIENNE C DEGOS L
Citation: P. Fenaux et al., ATRA FOLLOWED BY CHEMOTHERAPY (CT) VS ATRA PLUS CT AND THE ROLE OF MAINTENANCE THERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIRST INTERIM RESULTS OF APL-93 TRIAL, Blood, 90(10), 1997, pp. 533-533
BONE-MARROW VERSUS BLOOD AS SOURCE OF HEMATOPOIETIC STEM-CELLS AFTER HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA - A PROSPECTIVE, RANDOMIZED STUDY OF THE INTERGROUPE-FRANCAIS-DU-MYELOME (IFM)
Authors: HAROUSSEAU JL ATTAL M PAYEN C FACON T MICHAUX JL GUILHOT F MOCONDUIT M FUZIBET JG CAILLOT D DORVAUX V CAHN JY GROBOIS B STOPPA AM IFRAH N SOTTO JJ PIGNON B BATAILLE R
Citation: Jl. Harousseau et al., BONE-MARROW VERSUS BLOOD AS SOURCE OF HEMATOPOIETIC STEM-CELLS AFTER HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA - A PROSPECTIVE, RANDOMIZED STUDY OF THE INTERGROUPE-FRANCAIS-DU-MYELOME (IFM), Blood, 90(10), 1997, pp. 1018-1018
CLINICAL-FEATURES AND OUTCOME OF ATRA SYNDROME IN A LARGE MULTICENTERTRIAL IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Authors: DEBOTTON S DOMBRET H SANZ M SANMIGUEL J CAILLOT D ZITTOUN R GARDEMBAS M STAMATOULAS A CONDE E GUERCI A GARDIN C MAKHOUL DC REMAN O DELASERNA J LEFRERE F CHASTANG C DEGOS L FENAUX P
Citation: S. Debotton et al., CLINICAL-FEATURES AND OUTCOME OF ATRA SYNDROME IN A LARGE MULTICENTERTRIAL IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL), Blood, 90(10), 1997, pp. 1477-1477
SINGLE VERSUS DOUBLE TRANSPLANT IN MYELOMA - A RANDOMIZED TRIAL OF THE INTER-GROUPE-FRANCAIS-DU-MYELOME (IFM)
Authors: ATTAL M PAYEN C FACON T MICHAUX JL GUILHOT F MOCONDUIT M FUZIBET JG CAILLOT D DORVAUX V HAROUSSEAU JL CAHN JY GROBOIS B STOPPA AM IFRAH N SOTTO JJ PIGNON B BATAILLE R
Citation: M. Attal et al., SINGLE VERSUS DOUBLE TRANSPLANT IN MYELOMA - A RANDOMIZED TRIAL OF THE INTER-GROUPE-FRANCAIS-DU-MYELOME (IFM), Blood, 90(10), 1997, pp. 1859-1859
SURGICAL-MANAGEMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN NEUTROPENIC PATIENTS
Authors: BERNARD A CAILLOT D COUAILLIER JF CASASNOVAS O GUY H FAVRE JP
Citation: A. Bernard et al., SURGICAL-MANAGEMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN NEUTROPENIC PATIENTS, The Annals of thoracic surgery, 64(5), 1997, pp. 1441-1447
SYSTEMIC-SCLEROSIS AND CANCER - 21 NEW CA SES AND REVIEW OF LITERATURE
Authors: BIELEFELD P MEYER P CAILLOT D DALAC S CAMUS P TAVERNIER C COUILLAUT G CHALOPIN JM BESANCENOT JF
Citation: P. Bielefeld et al., SYSTEMIC-SCLEROSIS AND CANCER - 21 NEW CA SES AND REVIEW OF LITERATURE, La Revue de medecine interne, 17(10), 1996, pp. 810-813
NASOPHARYNGEAL LYMPHOMAS - FURTHER EVIDENCE FOR A NATURAL-KILLER-CELLORIGIN
Authors: PETRELLA T DELFAULARUE MH CAILLOT D MORCILLO JL CASASNOVAS O PORTIER H GAULARD P FARCET JP ARNOULD L
Citation: T. Petrella et al., NASOPHARYNGEAL LYMPHOMAS - FURTHER EVIDENCE FOR A NATURAL-KILLER-CELLORIGIN, Human pathology, 27(8), 1996, pp. 827-833
TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE
Authors: PIGNON B WITZ F DESABLENS B LEPRISE PY FRANCOIS S LINASSIER C BERTHOU C CAILLOT D LIOURE B CAHN JY CASASSUS P SADOUN A AUDHUY B GUYOTAT D BRIERE J VILQUE JP BARANGER L POLIN V BERTHAUD P HURTELOUP P HERVE P HAROUSSEAU JL
Citation: B. Pignon et al., TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE, British Journal of Haematology, 94(2), 1996, pp. 333-341
EPIDEMIOLOGIC CHARACTERISTICS OF MYELODYSPLASTIC SYNDROME IN A WELL-DEFINED FRENCH POPULATION
Authors: MAYNADIE M VERRET C MOSKOVTCHENKO P MUGNERET F PETRELLA T CAILLOT D CARLI PM
Citation: M. Maynadie et al., EPIDEMIOLOGIC CHARACTERISTICS OF MYELODYSPLASTIC SYNDROME IN A WELL-DEFINED FRENCH POPULATION, British Journal of Cancer, 74(2), 1996, pp. 288-290
COMBINATION OF QUININE AS A POTENTIAL REVERSING AGENT WITH MITOXANTRONE AND CYTARABINE FOR THE TREATMENT OF ACUTE LEUKEMIAS - A RANDOMIZED MULTICENTER STUDY
Authors: SOLARY E WITZ B CAILLOT D MOREAU P DESABLENS B CAHN JY SADOUN A PIGNON B BERTHOU C MALOISEL F GUYOTAT D CASASSUS P IFRAH N LAMY Y AUDHUY B COLOMBAT P HAROUSSEAU JL
Citation: E. Solary et al., COMBINATION OF QUININE AS A POTENTIAL REVERSING AGENT WITH MITOXANTRONE AND CYTARABINE FOR THE TREATMENT OF ACUTE LEUKEMIAS - A RANDOMIZED MULTICENTER STUDY, Blood, 88(4), 1996, pp. 1198-1205
PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET IP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 507-507
QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B HOANGNGOC L MALOSIEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N IFRAH N ABGRALL IP GUYOTAT D DUPRIEZ B PENY AM BRICE P PIGNON B LEPORRIER M LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP), Blood, 88(10), 1996, pp. 1807-1807
FRONT-LINE OR RESCUE AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOLLOWING A FIRST COURSE OF HIGH-DOSE MELPHALAN (HDM) IN MULTIPLE-MYELOMA (MM) - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL (CIAM PROTOCOL)
Authors: FACON T MARY JY HAROUSSEAU JL ATTAL M BOSLY A MICHAUX JL MALOISEL F SADOUN A MURON T ANGLARET B ROSSI JF QUIQUANDON I DESABLENS B WITZ F BENBOUCKER L FOUSSARD C GARDEMBAS M PIGNON B GROSBOIS B MONCONDUIT M AUTRAND C CASASSUS P CAILLOT D GRATECOS N MAISONNEUVE H FABBRO M PIEL G MATHIEUBOUE A JOUET JP BATAILLE R
Citation: T. Facon et al., FRONT-LINE OR RESCUE AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOLLOWING A FIRST COURSE OF HIGH-DOSE MELPHALAN (HDM) IN MULTIPLE-MYELOMA (MM) - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL (CIAM PROTOCOL), Blood, 88(10), 1996, pp. 2729-2729
EARLY DIAGNOSIS OF ANTHRACYCLINE CARDIOTO XICITY - VALUE OF RADIOISOTOPIC METHODS
Authors: MASSING JL CAILLOT D MOUHAT T SCHLESSER P SOLARY E
Citation: Jl. Massing et al., EARLY DIAGNOSIS OF ANTHRACYCLINE CARDIOTO XICITY - VALUE OF RADIOISOTOPIC METHODS, Archives des maladies du coeur et des vaisseaux, 89(1), 1996, pp. 57-62
AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER FIRST REMISSION INDUCTION TREATMENT IN MULTIPLE-MYELOMA - A REPORT OF THE FRENCH REGISTRY ON AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA
Authors: HAROUSSEAU JL ATTAL M DIVINE M MARIT G LEBLOND V STOPPA AM BOURHIS JH CAILLOT D BOASSON M ABGRALL JF FACON T LINASSIER C CAHN JY LAMY T TROUSSARD X GRATECOS N PIGNON B AUZANNEAU G BATAILLE R
Citation: Jl. Harousseau et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER FIRST REMISSION INDUCTION TREATMENT IN MULTIPLE-MYELOMA - A REPORT OF THE FRENCH REGISTRY ON AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA, Stem cells, 13, 1995, pp. 132-139
DER(16)T(1-16)(Q10-P10) IN MULTIPLE-MYELOMA - A NEW NONRANDOM ABNORMALITY THAT IS FREQUENTLY ASSOCIATED WITH BURKITTS-TYPE TRANSLOCATIONS
Authors: MUGNERET F SIDANER I FAVRE B MANONE L MAYNADIE M CAILLOT D SOLARY E
Citation: F. Mugneret et al., DER(16)T(1-16)(Q10-P10) IN MULTIPLE-MYELOMA - A NEW NONRANDOM ABNORMALITY THAT IS FREQUENTLY ASSOCIATED WITH BURKITTS-TYPE TRANSLOCATIONS, Leukemia, 9(2), 1995, pp. 277-281
IN-VITRO FLUCONAZOLE SUSCEPTIBILITY OF 16 4 CANDIDA SPP STRAINS ISOLATED FROM BLOOD CULTURES OR OROPHARYNX IN PATIENTS TREATED OR NOT TREATED PROPHYLACTICALLY WITH FLUCONAZOLE
Authors: BAILLY C VAGNER O AHO S LOPEZ J CAILLOT D CUISENIER B FUSSY A CHAVANET P FREYSZ M BONNIN A CAMERLYNCK P
Citation: C. Bailly et al., IN-VITRO FLUCONAZOLE SUSCEPTIBILITY OF 16 4 CANDIDA SPP STRAINS ISOLATED FROM BLOOD CULTURES OR OROPHARYNX IN PATIENTS TREATED OR NOT TREATED PROPHYLACTICALLY WITH FLUCONAZOLE, Medecine et maladies infectieuses, 25(8-9), 1995, pp. 919-925
LIPID-BASED FORMULATIONS OF AMPHOTERICIN-B - REPLY
Authors: CHAVANET P CAILLOT D
Citation: P. Chavanet et D. Caillot, LIPID-BASED FORMULATIONS OF AMPHOTERICIN-B - REPLY, Journal of antimicrobial chemotherapy, 35(5), 1995, pp. 711-713
COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AFTER FIRST REMISSION INDUCTION TREATMENT IN MULTIPLE-MYELOMA
Authors: MARIT G LEBLOND V STOPPA AM HAROUSSEAU JL ATTAL M DIVINE M MILPIED N BOURHIS JH CAILLOT D BOASSON M ABGRALL JF FACON T COLOMBAT P CAHN JY LAMY T TROUSSARD X GRATECOS N PIGNON B AUZANNEAU G
Citation: G. Marit et al., COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AFTER FIRST REMISSION INDUCTION TREATMENT IN MULTIPLE-MYELOMA, Bone marrow transplantation, 15(6), 1995, pp. 963-969
DIAGNOSTIC-VALUE OF SERUM IL-6 LEVEL IN MONOCLONAL GAMMOPATHIES
Authors: DUVILLARD L GUIGUET M CASASNOVAS RO CAILLOT D MONNIERZELLER V BERNARD A GUY H SOLARY E
Citation: L. Duvillard et al., DIAGNOSTIC-VALUE OF SERUM IL-6 LEVEL IN MONOCLONAL GAMMOPATHIES, British Journal of Haematology, 89(2), 1995, pp. 243-249
IMPAIRMENT OF DIASTOLIC FUNCTION DURING SHORT-TERM ANTHRACYCLINE CHEMOTHERAPY
Authors: COTTIN Y TOUZERY C COUDERT B GILLES A WALKER P MASSING JL TOUBEAU M RIEDINGERBERRIOLO A CAILLOT D LOUIS P WOLF JE BRUNOTTE F
Citation: Y. Cottin et al., IMPAIRMENT OF DIASTOLIC FUNCTION DURING SHORT-TERM ANTHRACYCLINE CHEMOTHERAPY, British Heart Journal, 73(1), 1995, pp. 61-64
GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
Authors: WITZ F HAROUSSEAU JL SADOUN A GUYOTAT D BERTHOU C CAHN JY GARDIN C LIOURE B WITZ B DESABLENS B IFRAH N PIGNON B LEPRISE PY AUDHUY B CAILLOT D CASASSUS P LINASSIER P CHRISTIAN B HURTELOUP P POLIN V TELLIER Z
Citation: F. Witz et al., GM-CSF DURING AND AFTER REMISSION INDUCTION TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 2036-2036
PROSPECTIVE MULTICENTRIC RANDOMIZED STUDY OF QUININE AS A POTENTIAL MDR-REVERSING AGENT FOR THE TREATMENT OF ACUTE LEUKEMIAS
Authors: SOLARY E WITZ B CAILLOT D MOREAU P DESABLENS B CAHN JY MALOISEL F SADOUN A PIGNON B GUYOTAT D CASASSUS P IFRAH N AUDHUY B BERTHOU C DELAIN M LAMY T HAROUSSEAU JL
Citation: E. Solary et al., PROSPECTIVE MULTICENTRIC RANDOMIZED STUDY OF QUININE AS A POTENTIAL MDR-REVERSING AGENT FOR THE TREATMENT OF ACUTE LEUKEMIAS, Blood, 86(10), 1995, pp. 3109-3109
INTENSIVE CHEMOTHERAPY (CT) WITH OR WITHOUT QUININE FOLLOWED BY AUTOLOGOUS BMT IN MYELODYSPLASTIC SYNDROMES (MDS) AND SECONDARY LEUKEMIAS (SL) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL
Authors: WATTEL P SOLARY E CAILLOT D IFRAH N BRIAN A MAHE B JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F VEIL A STOPPA AM GRATECOS N SADOUN A TILLY H BRICE P LIOURE B DESABLENS E PIGNON B ABGRALL IP LEPORRIER M DUPRIEZ B GUYOTAT D MERLAT A FENAUX P
Citation: P. Wattel et al., INTENSIVE CHEMOTHERAPY (CT) WITH OR WITHOUT QUININE FOLLOWED BY AUTOLOGOUS BMT IN MYELODYSPLASTIC SYNDROMES (MDS) AND SECONDARY LEUKEMIAS (SL) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL, Blood, 86(10), 1995, pp. 3204-3204
Risultati: 1-25 | 26-50 | 51-64